Inventors:
Dario G. Amodei - Princeton NJ, US
Mahalaxmi Gita Bangera - Renton WA, US
Xiaoyan Robert Bao - Cambridge MA, US
Anna Bershteyn - Somerville MA, US
Brett Bethke - Arlington MA, US
Philip A. Eckhoff - Bellevue WA, US
Kevin Michael Esvelt - Cambridge MA, US
Kyle B. Gustafson - Lausanne, CH
Edward K.Y. Jung - Bellevue WA, US
William Michael Kaminsky - Alexandria VA, US
Jordin T. Kare - Seattle WA, US
Lily Yvonne Kim - Brookline MA, US
Eric C. Leuthardt - St. Louis MO, US
Erez Lieberman - Cambridge MA, US
Ankur Moitra - Cambridge MA, US
Christopher Somogyi - Woodinville WA, US
Clarence T. Tegreene - Bellevue WA, US
Jeremiah James Zartman - Montgomery AL, US
International Classification:
A61K 49/00
A61K 9/00
A61K 35/12
A61K 35/68
A61K 35/74
A61K 35/64
A61K 35/00
A61P 43/00
US Classification:
424 91, 424400, 424422, 424 931, 424 934, 424 935, 424 937
Abstract:
Devices, methods, and systems are described for administration to at least one biological tissue of at least one device including at least one altered microorganism. In an embodiment, the altered microorganism includes at least one nucleic acid construct encoding at least one therapeutic agent.